AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|
10.4 C
New York
Thursday, October 22, 2026

Tag: treatment

Recovery.com Announces New Advertiser Certification Partnership with LegitScript

Recovery.com reinforces its commitment to advertiser quality with enhanced verification aligned with industry standards MADISON, Wis., July 14, 2025 /PRNewswire/ -- Recovery.com, a leading platform connecting...

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

Total Orthopedics and Sports Medicine Expands Multi-Specialty Spine and Orthopedic Care in New York

Total Orthopedics and Sports Medicine delivers coordinated, patient-centered orthopedic care across 14 New York locations. With over 20 board certified physicians, including Dr. Dante Leven, the practice offers comprehensive services in orthopedics, spine surgery, sports medicine, and rehabilitation, emphasizing collaboration and clinical excellence.
Total Orthopedics and Sports Medicine delivers coordinated, patient-centered orthopedic care across 14 New York locations. With over 20 board certified physicians, including Dr. Dante Leven, the practice offers comprehensive services in orthopedics, spine surgery, sports medicine, and rehabilitation, emphasizing collaboration and clinical excellence.

ASAP Dental Care Marks Milestone in Dental Implants with Over 9,600 Procedures Performed

Jacksonville, FL, July 14, 2025 (GLOBE NEWSWIRE) -- ASAP Dental Care, a leading provider of dental implants in Jacksonville and across Northeast Florida, has achieved a significant milestone in its surgical operations and patient care services, having successfully placed more than 9600 implants to date. The figure reflects cumulative procedures completed over the past years and includes both single-tooth and full-arch restorations.

Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025

PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual...

Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY® (crinecerfont) achieved clinically meaningful weight reductionsSubstantial improvements in insulin resistance were also...

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second quarter of 2025 after market close on Monday, August 4, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Concord Healthcare Announces Completion of China’s First Proton Therapy for Choroidal Malignant Melanoma

BEIJING, July 14, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM),...

Red Robin Gourmet Burgers, Inc. Announces “First Choice” Plan to Drive Long-Term Shareholder Value

Updates Second Quarter Financial Outlook ENGLEWOOD, Colo., July 14, 2025 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a full-service...

DeFi Development Corp. to Host X Spaces Event: “Our First SPS Forecast, Convertible Note Breakdown, & Company Update”

BOCA RATON, FL, July 14, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced it will host a live X Spaces conversation on Tuesday, July 15, 2025, at 1:30 p.m. Eastern Time, titled “DFDV Guidance Drop: First Forecasts, Convertible Note, & Company Update.”

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. (OTC: BLEG), a diversified holdings company, today announced significant changes in its leadership structure and a strategic merger initiative aimed at positioning the company for growth in the burgeoning addiction therapeutics sector.

Regrowing hearing cells: New gene functions discovered in zebrafish offer clues for future hearing loss treatments

Stowers scientists identify specific genes involved in zebrafish sensory hair cell regrowth, providing new insights that could inform future research into hearing loss treatments KANSAS...

The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant

FSR Early Career Fellowship Grant is designed to support early-career investigators in sarcoidosis.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTreatment